Daily Oncology News

Well Water a Suspected Cause of Bladder Cancer in New England

Well Water a Suspected Cause of Bladder Cancer in New England

Researchers believe arsenic exposure might contribute to higher-than-normal rates of bladder cancer in the region.

FDA Reconsidering Safety Training for Doctors Prescribing Opioids

FDA Reconsidering Safety Training for Doctors Prescribing Opioids

Next week, FDA committee of outside experts will meet to review risk-management plans

United States Health Report Card Finds Racial and Ethnic Disparities Persist

United States Health Report Card Finds Racial and Ethnic Disparities Persist

A new report from the U.S. Department of Health and Human Services finds improvements to infant mortality rates and number of insured citizens, but other problem areas persist.

Diet Can Affect Aggressiveness of Prostate Cancer

Diet Can Affect Aggressiveness of Prostate Cancer

Research also suggests that statins may help counteract harmful effect of fatty foods

AACR: Oral Bacteria Tied to Pancreatic Cancer Risk

AACR: Oral Bacteria Tied to Pancreatic Cancer Risk

Two strains of oral bacteria -- P. gingivalis and A. actinomycetemcomitans -- have been linked to higher risk of pancreatic cancer.

BRCA1 Mutation May Reduce Women's Fertility

BRCA1 Mutation May Reduce Women's Fertility

The BRCA1 mutation may speed the aging of a woman's ovaries,according to a recent report.

AACR: Regular Pre-Diagnosis Exercise Ups Prostate Cancer Survival

AACR: Regular Pre-Diagnosis Exercise Ups Prostate Cancer Survival

Researchers found that men with prostate cancer who had exercised regularly had the best outcomes.

Metformin May Reduce Cancer Mortality Risk for Women

Metformin May Reduce Cancer Mortality Risk for Women

Older women with diabetes and cancer taking metformin saw an increase in survival.

Older Age Patients with HNSCC Benefit from Afatinib vs Methotrexate

Older Age Patients with HNSCC Benefit from Afatinib vs Methotrexate

Patients age 65 years or older with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) did not have worse clinical outcomes.

Neratinib Not Superior to Trastuzumab for ERBB2+ Metastatic Breast Cancer

Neratinib Not Superior to Trastuzumab for ERBB2+ Metastatic Breast Cancer

Neratinib plus paclitaxel was not superior to trastuzumab plus paclitaxel with respect to progression-free survival as first-line treatment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs